Table 3

Quality of life of multiple sclerosis (MS) versus control patients

VariablesMS patientsControl
France:
Physical functionMean (SD)55.8 (26.0)96.2 (6.2)
95% CI50.4–61.294.0–98.4
n8930
 Psychological functionMean (SD)55.0 (20.6)71.1 (17.4)
95% CI50.7–59.264.9–77.3
n8930
 Social role functionMean (SD)67.0 (16.5)82.7 (11.0)
95% CI63.6–70.478.7–86.6
n8930
 General wellbeingMean (SD)31.3 (29.1)77.1 (14.6)
95% CI25.2–37.471.2–82.9
n8724
Germany:
Physical functionMean (SD)57.5 (29.3)94.8 (10.2)
95% CI51.4–63.691.2–98.5
n8930
 Psychological functionMean (SD)60.4 (22 .1)77.2 (14.5)
95% CI55.8–65.072.0–82.4
n8930
 Social role functionMean (SD)67.5 (15.6)84.8 (12.5)
95% CI64.3–70.880.3–89.2
n8930
 General wellbeingMean (SD)41.5 (29.1)72.3 (22.9)
95% CI35.4–47.663.8–80.8
n8828
United Kingdom:
Physical functionMean (SD)44.3 (27.0)82.3 (22.4)
95% CI38.6–50.074.3–90.3
n8630
 PsychologicalMean (SD)60.9 (17.5)74.5 (17.8)
95% CI57.2–64.668.2–80.9
n8730
 Social role functionMean (SD)65.4 (15.2)78.0 (18.2)
95% CI62.2–68.671.5–84.5
n8730
 General wellbeingMean (SD)34.2 (27.5)62.0 (22.3)
95% CI28.1–40.253.6–70.5
n7927
  • p⩽ 0.001, analysis of covariance (ANCOVA) in all cases.